Enanta Pharma (ENTA) Misses Q3 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. CRWD
4. VRTX
5. ON
6. CHKP
7. HNGE
8. INSP
9. RXRX
10. MTCH

Go back to Enanta Pharma (ENTA) Misses Q3 EPS by 6c

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2015

August 6, 2015 4:01 PM EDT

Conference Call and Webcast Today at 4:30 p.m. ET

Cash and marketable securities totaled $212 million at June 30, 2015 Existing financial resources and anticipated cash flows to fund continued operations and advance proprietary pipeline

WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc., (NASDAQ: ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today reported financial results for its fiscal third quarter ended June 30, 2015.

Fiscal Third Quarter Ended June 30, 2015 Financial... More